Dachaigh › Cancer Pancreatic › Illinois › Chicago
Sgrùdaidhean clionaigeach Cancer Pancreatic ann an Chicago, IL
Tha 20 sgrùdaidhean airson Cancer Pancreatic a’ lorg phàirtichean aig làraichean ann agus timcheall air Chicago (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- Research Site, Chicago
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A’ fastadhÌre 3
- City of Hope, Chicago
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
A’ fastadhÌre 1
- Northwestern University, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A’ fastadhÌre 1
- University of Chicago Hospital, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 2
- University of Illinois Cancer Center, Chicago
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
A’ fastadhÌre 3
- University of Chicago Medical Center, Chicago
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A’ fastadhÌre 3
- Investigative Site US079, Chicago
CREO - Microwave Ablation Feasibility Study
A’ fastadh
- Rush University Medical Center, Chicago
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
A’ fastadhSgrùdadh amharc
- Northwestern University, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
A’ fastadhÌre 1/2
- Northwestern University, Chicago
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
A’ fastadhÌre 3
- Northwestern University, Chicago
- University of Illinois, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Pancreatic Cancer Early Detection Consortium
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- University of Chicago Medicine, Chicago
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
A’ fastadhÌre 2
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A’ fastadhÌre 1
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
Lidocaine Infusion in Pancreatic Cancer
A’ fastadhÌre 1 tràth
- University of Illnois at Chicago, Chicago
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
A’ fastadhÌre 3
- Northwestern University, Chicago
- University of Illinois, Chicago
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
A’ fastadhÌre 2
- Ohio State University-Telemedicine, Chicago
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
A’ fastadhSgrùdadh amharc
- Advocate Illinois Masonic Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
A’ fastadhÌre 2
- Northwestern University, Chicago
Sgrùdaidhean Cancer Pancreatic ann am bailtean eile
- Houston, TX61 sgrùdaidhean
- New York City, NY60 sgrùdaidhean
- Boston, MA43 sgrùdaidhean
- Nashville, TN39 sgrùdaidhean
- Los Angeles, CA35 sgrùdaidhean
- St. Louis, MO33 sgrùdaidhean
- Arlington, VA33 sgrùdaidhean
- Baltimore, MD31 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Philadelphia, PA26 sgrùdaidhean
- Tampa, FL26 sgrùdaidhean
- Durham, NC24 sgrùdaidhean
Sgrùdaidhean eile ann an Chicago
- Aillse Sgamhain Neo-chealla-beag61 sgrùdaidhean
- Aillse a' bhroilleach59 sgrùdaidhean
- Aillse (gach seòrsa)51 sgrùdaidhean
- Ailse metastatach45 sgrùdaidhean
- Aillse Prostata45 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Obesity41 sgrùdaidhean
- Cancer Ovarian36 sgrùdaidhean
- Aillse colorectal34 sgrùdaidhean
- Buailteach34 sgrùdaidhean
- Fàilligeadh a' Chridhe31 sgrùdaidhean
- Ro-throm29 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.